SVB Leerink Downgrades Translate Bio (TBIO) to Market Perform
Tweet
Share
E-mailGet Alerts TBIO Hot Sheet
Price: $3.23 --0%
Rating Summary:
6 Buy, 5 Hold, 0 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 2 | Down: 8 | New: 5
Rating Summary:
6 Buy, 5 Hold, 0 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 2 | Down: 8 | New: 5
Join SI Premium – FREE
SVB Leerink analyst Geoffrey Porges downgraded Translate Bio (NASDAQ: TBIO) from Outperform to Market Perform with a price target of $18.00 (from $21.00).
For an analyst ratings summary and ratings history on Translate Bio click here. For more ratings news on Translate Bio click here.
Shares of Translate Bio closed at $15.90 yesterday.
You May Also Be Interested In
- Citi Downgrades Lend Lease Group (LLC:AU) (LLESY) to Neutral
- Berenberg Downgrades Segro PLC (SGRO:LN) (SEGXF) to Hold
- UBS Downgrades Scor SE (SCR:FP) (SCRYY) to Sell
Create E-mail Alert Related Categories
Analyst PT Change, DowngradesSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
